Eutilex -Model EU307(GPC3-IL18) -Hepatocellular Carcinoma and Non-Small Cell Lung Cancer
FromEutilex Co.,Ltd.
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th generation GPC3 CAR-T required than other groups to remove HCC.
Most popular related searches
non-small cell lung cancer
in vivo efficacy
cancer cell
cancerous target
hepatocellular carcinoma
lung cancer
cancer drug
car-t cell
lung cell
drug target
Indication
GPC3 expressing cancer
Target /Drug class
GPC3 expressing cancer cell / CAR-T
Development Stage
Non-clinical
